Lv3
210 积分 2025-11-21 加入
Inhibitors and PROTACs of CDK2: challenges and opportunities
3天前
已完结
Development of MPS1 Inhibitors: Recent Advances and Perspectives
3天前
已完结
Integrated machine learning and multi-omics analysis identifies ALOX5 as a potential therapeutic target for tubulointerstitial inflammation in diabetic kidney disease
6天前
已完结
Furo[2,3- f ]quinazolin-7(6 H )-one Derivatives as Potent, Selective, and Orally Bioavailable MAT2A Inhibitors for MTAP-Deficient Cancer Therapy
6天前
已完结
Furo[2,3- f ]quinazolin-7(6 H )-one Derivatives as Potent, Selective, and Orally Bioavailable MAT2A Inhibitors for MTAP-Deficient Cancer Therapy
14天前
已完结
Lack of Cancer Specificity of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 in Combination With Recombinant Methioninase In Vitro
21天前
已完结
Discovery of Potential Scaffolds for Methionine Adenosyltransferase 2A (MAT2A) Inhibitors: Virtual Screening, Synthesis, and Biological Evaluation
3个月前
已完结
Lack of Cancer Specificity of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 in Combination With Recombinant Methioninase In Vitro
4个月前
已完结
Inhibitors and PROTACs of CDK2: challenges and opportunities
4个月前
已完结
Development of MPS1 Inhibitors: Recent Advances and Perspectives
4个月前
已完结
皖公网安备34019202002308
